VA DOD Updates Asthma Framework - Summary - MDSpire
Advertisement
VA DOD Updates Asthma Framework
The 2025 US Department of Veterans Affairs and US Department of Defense asthma guideline introduces 21 evidence-based recommendations for primary care, redefining stepwise treatment, comorbidity management, and reliever strategy.
To provide updated clinical practice guidelines for the primary care management of asthma based on emerging evidence, specifically targeting chronic asthma in patients older than 5 years.
Approach:
Key Findings:
Single-device maintenance and reliever therapy (SMART) reduced severe asthma exacerbations by about one-third in randomized trials.
The updated guidelines recommend ICS for all patients, regardless of symptom frequency.
For patients aged 12 years or older with mild asthma, ICS combined with rapid-onset LABA is recommended for control and relief.
Interpretation:
The guidelines represent a significant shift towards anti-inflammatory treatment strategies in asthma management, aligning with recent evidence.
Limitations:
The guidelines do not address acute exacerbation management, which may limit their applicability in urgent care settings.
Biologic therapies are deferred to subspecialists, limiting primary care applicability.
Conclusion:
The 2025 VA/DoD asthma clinical practice guideline streamlines asthma management by endorsing ICS-containing therapies and step-up strategies, marking a significant shift in treatment approach.
Seven companies will participate in a two-phase program that provides early FDA technical guidance during development of new US pharmaceutical manufacturing facilities.
